文献速递脊柱关节炎

临床试验与日常实践中银屑病关节炎结局评估的现状

The state of the art-psoriatic arthritis outcome assessment in clinical trials and daily practice.
PubMed 文献 · Lancet Rheumatol · 2022-01-20

银屑病关节炎具有异质性,临床试验与日常实践在优化结局指标方面面临挑战。本文综述了结局指标选择的现有证据,涵盖单维与多维结局、连续与二分测量,以及这些方法在试验与临床实践中的可行性。

要点

  • 银屑病关节炎无测量疾病活动度或影响的黄金标准工具。
  • OMERACT核心域集涵盖关节、肌腱、皮肤、脊柱等多组织受累及异质性影响。
  • 结局指标选择需权衡单维与多维、连续与二分测量及可行性。

核心结论

  • 银屑病关节炎在临床试验与日常实践中优化结局指标存在重大挑战,尚无测量疾病活动度或影响的黄金标准工具。

研究设计与样本

  • 本文为综述,总结当前关于结局指标选择的证据。

主要发现

  • OMERACT银屑病关节炎核心域集强调疾病累及关节、肌腱、皮肤和脊柱等多组织,并对个体产生异质性影响。

关键数值与推荐

  • 综述汇总了单维与多维结局、连续与二分测量,以及这些方法在试验与临床实践中可行性的现有证据。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psoriatic arthritis is a heterogeneous condition with substantial challenges in optimising outcome measures for both clinical trials and daily practice. As with other inflammatory arthritides, there is no gold standard instrument for measuring disease activity or impact, both of which are key to evaluate therapeutic approaches in trials and monitor disease in daily practice. A wide range of domains have been highlighted in the Outcome Measures in Rheumatology (OMERACT) core domain set for psoriatic arthritis; reflecting the disease involvement in multiple tissues (joints, tendons, skin, and spine) and the heterogenous impact of the disease on individuals. This Review summarises the current evidence around outcome measure selection, considering factors such as unidimensional versus multidimensional outcomes, continuous versus binary measures, and the feasibility of these approaches in trials compared with clinical practice.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Day J, Antony A, Tillett W, et al. The state of the art-psoriatic arthritis outcome assessment in clinical trials and daily practice. Lancet Rheumatol. 2022. PMID: 38288938. doi:10.1016/S2665-9913(21)00349-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。